Ophthalmology^® Glaucoma is the American Academy of Ophthalmology's scientific publication focused exclusively on glaucoma-related conditions and treatments. The Academy launched this journal in partnership with the American Glaucoma Society to help you stay on top of current glaucoma research and learn about advances in medical drug treatment, surgery, technology and science.

Ophthalmology Glaucoma expands Ophthalmology’s publishing capacity to ensure that important advances are accessible to practicing ophthalmologists and researchers.

As a testament to the journal's high caliber, Ophthalmology Glaucoma is now fully indexed by MEDLINE/PubMed, with a 2.8 Impact Factor*.

Your two-year, 12-issue subscription includes a new print issue bi-monthly and online access to current and archive issues.

Ophthalmology Glaucoma is a free benefit to members of the American Glaucoma Society. AGS members must go to americanglaucomasociety.net to access their member benefit subscription. If you are an AGS member who has questions about your subscription email ags@aao.org or call +1 415.561.8587 8:30 a.m. to 4:30 p.m., Pacific Time, Monday through Friday.

Academy members may subscribe via the online store at a special discounted rate.

Those not members of the Academy or the American Glaucoma Society may subscribe via Elsevier at aao.org/glaucomajournal.

For information about submitting your paper to Ophthalmology Glaucoma, visit aao.org/glaucomajournal.

*Source: Journal Citation Report Impact Factor 2022

All content published by the Academy is protected by copyright law and the Terms of Service. This content may not be reproduced, copied, or put into any artificial intelligence program, including large language and generative AI models, without permission from the Academy.